These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 16880521)

  • 21. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
    Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
    Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peroxisome proliferator-activated receptor activity is involved in the osteoblastic differentiation regulated by bone morphogenetic proteins and tumor necrosis factor-α.
    Takano M; Otsuka F; Matsumoto Y; Inagaki K; Takeda M; Nakamura E; Tsukamoto N; Miyoshi T; Sada KE; Makino H
    Mol Cell Endocrinol; 2012 Jan; 348(1):224-32. PubMed ID: 21888945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BMP-2 promotes differentiation of osteoblasts and chondroblasts in Runx2-deficient cell lines.
    Liu T; Gao Y; Sakamoto K; Minamizato T; Furukawa K; Tsukazaki T; Shibata Y; Bessho K; Komori T; Yamaguchi A
    J Cell Physiol; 2007 Jun; 211(3):728-35. PubMed ID: 17226753
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCAAT/Enhancer-binding protein homologous protein (CHOP) decreases bone formation and causes osteopenia.
    Pereira RC; Stadmeyer LE; Smith DL; Rydziel S; Canalis E
    Bone; 2007 Mar; 40(3):619-26. PubMed ID: 17095306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCAAT/enhancer-binding protein-beta has a role in osteoblast proliferation and differentiation.
    Iyer VV; Kadakia TB; McCabe LR; Schwartz RC
    Exp Cell Res; 2004 Apr; 295(1):128-37. PubMed ID: 15051496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine promotes osteoblast differentiation by Runx2 activation with p38 MAPK.
    Lee HW; Suh JH; Kim HN; Kim AY; Park SY; Shin CS; Choi JY; Kim JB
    J Bone Miner Res; 2008 Aug; 23(8):1227-37. PubMed ID: 18410224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poncirin promotes osteoblast differentiation but inhibits adipocyte differentiation in mesenchymal stem cells.
    Yoon HY; Yun SI; Kim BY; Jin Q; Woo ER; Jeong SY; Chung YS
    Eur J Pharmacol; 2011 Aug; 664(1-3):54-9. PubMed ID: 21550337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction of protein phosphatase 2A Cα enhances bone formation and osteoblast differentiation through the expression of bone-specific transcription factor Osterix.
    Okamura H; Yoshida K; Ochiai K; Haneji T
    Bone; 2011 Sep; 49(3):368-75. PubMed ID: 21683816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C/EBPzeta (CHOP/Gadd153) is a negative regulator of LPS-induced IL-6 expression in B cells.
    Gao H; Schwartz RC
    Mol Immunol; 2009 Dec; 47(2-3):390-7. PubMed ID: 19782405
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCAAT/enhancer-binding proteins (C/EBP) beta and delta activate osteocalcin gene transcription and synergize with Runx2 at the C/EBP element to regulate bone-specific expression.
    Gutierrez S; Javed A; Tennant DK; van Rees M; Montecino M; Stein GS; Stein JL; Lian JB
    J Biol Chem; 2002 Jan; 277(2):1316-23. PubMed ID: 11668178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Transcription Factor EB (TFEB) Regulates Osteoblast Differentiation Through ATF4/CHOP-Dependent Pathway.
    Yoneshima E; Okamoto K; Sakai E; Nishishita K; Yoshida N; Tsukuba T
    J Cell Physiol; 2016 Jun; 231(6):1321-33. PubMed ID: 26519689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serpina3n, Dominantly Expressed in Female Osteoblasts, Suppresses the Phenotypes of Differentiated Osteoblasts in Mice.
    Ishida M; Kawao N; Okada K; Tatsumi K; Sakai K; Nishio K; Kaji H
    Endocrinology; 2018 Nov; 159(11):3775-3790. PubMed ID: 30304388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Upregulation of Runt-Related Transcription Factor-2 Through CCAAT Enhancer Binding Protein-β Signaling Pathway in Microglial BV-2 Cells Exposed to ATP.
    Nakazato R; Takarada T; Ikeno S; Nakamura S; Kutsukake T; Hinoi E; Yoneda Y
    J Cell Physiol; 2015 Oct; 230(10):2510-21. PubMed ID: 25802132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual Regulatory Role of Polyamines in Adipogenesis.
    Brenner S; Bercovich Z; Feiler Y; Keshet R; Kahana C
    J Biol Chem; 2015 Nov; 290(45):27384-27392. PubMed ID: 26396188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. YY1 represses the transcriptional activity of Runx2 in C2C12 cells.
    Jeong HM; Choi YH; Lee SH; Lee KY
    Mol Cell Endocrinol; 2014 Mar; 383(1-2):103-10. PubMed ID: 24325869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Col1a1 promoter-targeted expression of p20 CCAAT enhancer-binding protein beta (C/EBPbeta), a truncated C/EBPbeta isoform, causes osteopenia in transgenic mice.
    Harrison JR; Huang YF; Wilson KA; Kelly PL; Adams DJ; Gronowicz GA; Clark SH
    J Biol Chem; 2005 Mar; 280(9):8117-24. PubMed ID: 15598659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glucocorticoids induce the differentiation of a mesenchymal progenitor cell line, ROB-C26 into adipocytes and osteoblasts, but fail to induce terminal osteoblast differentiation.
    Ito S; Suzuki N; Kato S; Takahashi T; Takagi M
    Bone; 2007 Jan; 40(1):84-92. PubMed ID: 16949358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Canonical Notch signaling is required for bone morphogenetic protein-mediated human osteoblast differentiation.
    Wagley Y; Chesi A; Acevedo PK; Lu S; Wells AD; Johnson ME; Grant SFA; Hankenson KD
    Stem Cells; 2020 Oct; 38(10):1332-1347. PubMed ID: 32535942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel RBP-J kappa-dependent switch from C/EBP beta to C/EBP zeta at the C/EBP binding site on the C-reactive protein promoter.
    Singh PP; Voleti B; Agrawal A
    J Immunol; 2007 Jun; 178(11):7302-9. PubMed ID: 17513780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.